Silent reflux risk after Weight-Loss surgery revealed
NCT ID NCT03705416
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 250 obese adults who are having a weight-loss procedure—either surgery or an endoscopic stomach reduction. The goal is to see how often acid reflux (GERD) develops afterward, including silent reflux with no symptoms. By tracking symptoms and using tests, researchers hope to learn which procedures are safer for reflux-prone patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose the best weight-loss procedure to avoid or manage acid reflux in obese patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to all patients or procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Legacy Oregon Clinic
Portland, Oregon, 97213, United States
-
Memorial Hermann Health System
Houston, Texas, 77401, United States
-
Northwell Health
New Hyde Park, New York, 11040, United States
-
Utah-Health: University of Utah
Salt Lake City, Utah, 84132, United States
-
Weill Cornell
New York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test